Key Points
- Director Thomas Errico bought 10,000 electroCore shares for $54,400 at an average price of $5.44, increasing his holdings by 2.75% to 373,904 shares.
- ElectroCore reported a quarterly loss of $0.13 per share, better than analysts’ expected $0.27 loss, while revenue of $9.69 million fell short of the $10.93 million estimate.
- Analyst opinions are mixed, with one Buy, one Hold, and one Sell rating; the consensus is Hold, with a stated price target of $18.
electroCore, Inc. (NASDAQ:ECOR - Get Free Report) Director Thomas Errico acquired 10,000 shares of electroCore stock in a transaction that occurred on Thursday, November 12th. The shares were bought at an average price of $5.44 per share, for a total transaction of $54,400.00. Following the transaction, the director owned 373,904 shares of the company's stock, valued at $2,034,037.76. This represents a 2.75% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
electroCore Stock Performance
NASDAQ ECOR opened at $4.84 on Tuesday. The stock's fifty day moving average is $8.92 and its two-hundred day moving average is $7.72. The firm has a market capitalization of $44.67 million, a P/E ratio of -3.48 and a beta of 1.23. electroCore, Inc. has a fifty-two week low of $4.37 and a fifty-two week high of $12.70.
electroCore (NASDAQ:ECOR - Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.14. The company had revenue of $9.69 million during the quarter, compared to analyst estimates of $10.93 million. As a group, sell-side analysts forecast that electroCore, Inc. will post -1.17 EPS for the current year.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of electroCore in a report on Monday, September 21st. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $18.00.
Read Our Latest Research Report on ECOR
Institutional Trading of electroCore
An institutional investor recently bought a new stake in electroCore stock. Cetera Investment Advisers purchased a new stake in electroCore, Inc. (NASDAQ:ECOR - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 32,950 shares of the company's stock, valued at approximately $357,000. Cetera Investment Advisers owned 0.36% of electroCore as of its most recent filing with the SEC. 26.74% of the stock is currently owned by institutional investors and hedge funds.
About electroCore
(
Get Free Report)
electroCore is a medical technology company that develops non-invasive bioelectronic therapies. Its products use non-invasive vagus nerve stimulation (nVNS), which delivers gentle electrical stimulation through the skin to activate the vagus nerve. The company's gammaCore device is used for the treatment of certain headache conditions, including migraine and cluster headache, subject to its regulatory clearances and indications. electroCore also offers Truvaga, a consumer wellness product that uses non-invasive vagus nerve stimulation.
See Also

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].